ARTICLE | Company News
Debiopharm, GenOdyssee deal
June 9, 2003 7:00 AM UTC
GenOdyssee granted an exclusive global license to Debiopharm to develop and commercialize a GenOdyssee compound. The compound will be selected from a predefined GenOdyssee portfolio of five candidates...